Microbial etiology of pneumonia: epidemiology, diagnosis and resistance patterns

C Cilloniz, I Martin-Loeches, C Garcia-Vidal… - International journal of …, 2016 - mdpi.com
Globally, pneumonia is a serious public health concern and a major cause of mortality and
morbidity. Despite advances in antimicrobial therapies, microbiological diagnostic tests and …

Antimicrobial resistant Streptococcus pneumoniae: prevalence, mechanisms, and clinical implications

R Cherazard, M Epstein, TL Doan, T Salim… - American journal of …, 2017 - journals.lww.com
Background: Streptococcus pneumoniae is a major cause of pneumonia, meningitis, sepsis,
bacteremia, and otitis media. S. pneumoniae has developed increased resistance to …

Diagnosis and treatment of community‐acquired pneumonia in adults: 2016 clinical practice guidelines by the Chinese Thoracic Society, Chinese Medical Association

B Cao, Y Huang, DY She, QJ Cheng… - The clinical …, 2018 - Wiley Online Library
Community‐acquired pneumonia (CAP) in adults is an infectious disease with high
morbidity in China and the rest of the world. With the changing pattern in the etiological …

Challenges in severe community-acquired pneumonia: a point-of-view review

A Torres, JD Chalmers, CS Dela Cruz… - Intensive care …, 2019 - Springer
Purpose Severe community-acquired pneumonia (SCAP) is still associated with substantial
morbidity and mortality. In this point-of-view review paper, a group of experts discuss the …

Advances in the causes and management of community acquired pneumonia in adults

RG Wunderink, G Waterer - Bmj, 2017 - bmj.com
Community acquired pneumonia remains a common cause of morbidity and mortality.
Usually, the causal organism is not identified and treatment remains empiric. Recent …

The burden of community-acquired bacterial pneumonia in the era of antibiotic resistance

P Peyrani, L Mandell, A Torres… - Expert review of …, 2019 - Taylor & Francis
Introduction: Community-acquired pneumonia (CAP) is a significant global health problem
and leading cause of death and hospitalization in both the US and abroad. Increasing …

British Thoracic Society guideline for the use of long-term macrolides in adults with respiratory disease

D Smith, IA Du Rand, C Addy… - BMJ open …, 2020 - bmjopenrespres.bmj.com
The full British Thoracic Society (BTS) guideline for the use of long-term macrolides in adults
with respiratory disease is published in Thorax. The following is a summary of the …

The global burden of community-acquired pneumonia in adults, encompassing invasive pneumococcal disease and the prevalence of its associated cardiovascular …

R Anderson, C Feldman - International Journal of Molecular Sciences, 2023 - mdpi.com
Despite innovative advances in anti-infective therapies and vaccine development
technologies, community-acquired pneumonia (CAP) remains the most persistent cause of …

Antimicrobial Resistance Among Streptococcus pneumoniae

C Cillóniz, C Garcia-Vidal, A Ceccato… - Antimicrobial Resistance in …, 2018 - Springer
Antibiotic resistance in Streptococcus pneumoniae (pneumococcus), the main pathogen
responsible for community-acquired pneumonia (CAP), meningitis, bacteremia, and otitis …

Immunomodulation by macrolides: therapeutic potential for critical care

TDY Reijnders, A Saris, MJ Schultz… - The Lancet Respiratory …, 2020 - thelancet.com
Critical illness is associated with immune dysregulation, characterised by concurrent
hyperinflammation and immune suppression. Hyperinflammation can result in collateral …